{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:58:56Z","timestamp":1793091536959,"version":"4.5.0"},"reference-count":136,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/rmr.0b013e318181e0be","type":"journal-article","created":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T07:06:37Z","timestamp":1219043197000},"page":"81-96","source":"Crossref","is-referenced-by-count":90,"title":["Research Applications of Magnetic Resonance Spectroscopy to Investigate Psychiatric Disorders"],"prefix":"10.1097","volume":"19","author":[{"given":"Stephen R.","family":"Dager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva M.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd L.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Posse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210213","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1126\/science.3279509","article-title":"Brain imaging: applications in psychiatry.","volume":"239","author":"Andreasen","year":"1988","journal-title":"Science"},{"key":"R2-3-20210213","first-page":"191","article-title":"Clinical applications of magnetic resonance spectroscopy.","volume":"10","author":"Ross","year":"1994","journal-title":"Magn Reson Med"},{"key":"R4-3-20210213","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/242190a0","article-title":"Image formation by induced local interactions: examples employing nuclear magnetic resonance.","volume":"242","author":"Lauterbur","year":"1973","journal-title":"Nature"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1088\/0022-3719\/6\/22\/007","article-title":"NMR diffraction in solids?","volume":"6","author":"Mansfield","year":"1973","journal-title":"J Phys C Solid State Phys"},{"key":"R7-3-20210213","first-page":"1","article-title":"Physiological NMR spectroscopy: from isolated cells to man.","volume":"508","author":"Cohen","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"R8-3-20210213","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1176\/ajp.2006.163.4.710","article-title":"Brain pH response to hyperventilation in panic disorder: preliminary evidence for altered acid-base regulation.","volume":"163","author":"Friedman","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-3223(88)90018-2","article-title":"In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy.","volume":"23","author":"Renshaw","year":"1988","journal-title":"Biol Psychiatry"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1176\/appi.ajp.159.5.755","article-title":"19F measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.","volume":"159","author":"Strauss","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/ajp.156.2.229","article-title":"Human brain metabolic response to caffeine and the effects of tolerance.","volume":"156","author":"Dager","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R12-3-20210213","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mrm.1910300405","article-title":"Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.","volume":"30","author":"Kreis","year":"1993","journal-title":"Magn Reson Med"},{"key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.neuroimage.2003.11.014","article-title":"Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla.","volume":"21","author":"Schubert","year":"2004","journal-title":"Neuroimage"},{"key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/jmre.1999.1895","article-title":"Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.","volume":"141","author":"Pfeuffer","year":"1999","journal-title":"J Magn Reson"},{"key":"R15-3-20210213","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mrm.21415","article-title":"Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T.","volume":"58","author":"Li","year":"2007","journal-title":"Magn Reson Med"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mrm.10104","article-title":"In vivo GABA editing using a novel doubly selective multiple quantum filter.","volume":"47","author":"Shen","year":"2002","journal-title":"Magn Reson Med"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9258(18)65789-8","article-title":"N-Acetyl-l-aspartic acid in brain.","volume":"219","author":"Tallan","year":"1956","journal-title":"J Biol Chem"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/WNL.52.7.1384","article-title":"Quantitative proton MRS predicts outcome after traumatic brain injury.","volume":"52","author":"Friedman","year":"1999","journal-title":"Neurology"},{"key":"R19-3-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0149-7634(89)80048-X","article-title":"N-Acetyl-l-aspartic acid: a literature review of a compound prominent in 1H NMR spectroscopic studies of brain.","volume":"13","author":"Birken","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archpsyc.57.1.90","article-title":"Mind glue: implications of glial cell biology for psychiatry.","volume":"57","author":"Coyle","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1471-4159.2000.0750453.x","article-title":"Functions of N-acetyl-l-aspate and N-acetyl-l-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.","volume":"75","author":"Baslow","year":"2000","journal-title":"J Neurochem"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.0750443.x","article-title":"N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.","volume":"75","author":"Neale","year":"2000","journal-title":"J Neurochem"},{"key":"R23-3-20210213","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1148\/radiology.176.2.2164237","article-title":"Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain.","volume":"176","author":"van der Knaap","year":"1990","journal-title":"Radiology"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1203\/00006450-199112000-00017","article-title":"Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain.","volume":"30","author":"Huppi","year":"1991","journal-title":"Pediatr Res"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0006-3223(98)00249-2","article-title":"Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study.","volume":"45","author":"Moore","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1523\/JNEUROSCI.16-03-00877.1996","article-title":"Metabolic coupling between glia and neurons.","volume":"16","author":"Tsacopoulos","year":"1996","journal-title":"J Neurosci"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1176\/ajp.152.5.666","article-title":"Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects.","volume":"152","author":"Dager","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","article-title":"Brain metabolic alterations in medication-free patients with bipolar disorder.","volume":"61","author":"Dager","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1528-1157.2002.38901.x","article-title":"Glutamate-glutamine cycling in the epileptic human hippocampus.","volume":"43","author":"Petroff","year":"2002","journal-title":"Epilepsia"},{"key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra.","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mrm.20063","article-title":"Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES.","volume":"51","author":"Kanowski","year":"2004","journal-title":"Magn Reson Med"},{"key":"R34-3-20210213","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.60.1.100","article-title":"Regional brain chemical alterations in young children with autism spectrum disorder.","volume":"60","author":"Friedman","year":"2003","journal-title":"Neurology"},{"key":"R35-3-20210213","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0024-3205(92)90404-D","article-title":"Localized magnetic resonance spectroscopy measurement of brain lactate during intravenous 0.5 M sodium l-lactate infusion in healthy volunteers.","volume":"51","author":"Dager","year":"1992","journal-title":"Life Sci"},{"key":"R36-3-20210213","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mrm.21067","article-title":"Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging.","volume":"56","author":"Otazo","year":"2006","journal-title":"Magn Reson Med"},{"key":"R37-3-20210213","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mrm.1910370609","article-title":"In vivo measurement of regional brain metabolic response to hyperventilation using functional proton echo-planar spectroscopic imaging (PEPSI).","volume":"37","author":"Posse","year":"1997","journal-title":"Magn Reson Med"},{"key":"R38-3-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mrm.21119","article-title":"Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain.","volume":"57","author":"Lin","year":"2007","journal-title":"Magn Reson Med"},{"key":"R39-3-20210213","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mrm.21287","article-title":"Proton echo planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla.","volume":"58","author":"Posse","year":"2007","journal-title":"Magn Reson Med"},{"key":"R40-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004728-199301000-00001","article-title":"Short echo time proton MR spectroscopic imaging.","volume":"17","author":"Posse","year":"1993","journal-title":"J Comput Assist Tomogr"},{"key":"R42-3-20210213","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1192\/S0007125000291848","article-title":"Psychiatry and the new magnetic resonance era.","volume":"157","author":"Lock","year":"1990","journal-title":"Br J Psychiatry"},{"key":"R43-3-20210213","first-page":"249","article-title":"Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.","volume":"6","author":"Dager","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"R44-3-20210213","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-3223(01)01313-0","article-title":"Magnetic resonance spectroscopy: current and future applications in psychiatric research.","volume":"51","author":"Lyoo","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R45-3-20210213","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1523\/JNEUROSCI.1712-06.2006","article-title":"The developmental neurobiology of autism spectrum disorder.","volume":"26","author":"DiCicco-Bloom","year":"2006","journal-title":"J Neurosci"},{"key":"R46-3-20210213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/1467-8624.00411","article-title":"Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay.","volume":"73","author":"Dawson","year":"2002","journal-title":"Child Dev"},{"key":"R47-3-20210213","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1176\/appi.ajp.162.6.1133","article-title":"Pervasive developmental disorders in preschool children: confirmation of high prevalence.","volume":"162","author":"Chakrabarti","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R48-3-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004583-199001000-00020","article-title":"Seizure disorders in autism.","volume":"29","author":"Volkmar","year":"1990","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"R49-3-20210213","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0387-7604(99)00124-2","article-title":"Epilepsy in adolescents and young adults with autistic disorder.","volume":"22","author":"Giovanardi","year":"2000","journal-title":"Brain Dev"},{"key":"R50-3-20210213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.57.2.245","article-title":"Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study.","volume":"57","author":"Courchesne","year":"2001","journal-title":"Neurology"},{"key":"R51-3-20210213","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1212\/WNL.59.2.184","article-title":"Brain structural abnormalities in young children with autism spectrum disorder.","volume":"59","author":"Sparks","year":"2002","journal-title":"Neurology"},{"key":"R52-3-20210213","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archpsyc.62.12.1366","article-title":"Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years.","volume":"62","author":"Hazlett","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R53-3-20210213","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archpsyc.63.7.786","article-title":"Gray and white matter brain chemistry in young children with autism.","volume":"63","author":"Friedman","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R54-3-20210213","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.biopsych.2006.07.022","article-title":"Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study.","volume":"61","author":"DeVito","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R55-3-20210213","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2004.00574.x","article-title":"Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.","volume":"30","author":"Mukaetova-Ladinska","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Pt 5","key":"R56-3-20210213","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/brain\/121.5.889","article-title":"A clinicopathological study of autism.","volume":"121","author":"Bailey","year":"1998","journal-title":"Brain"},{"key":"R57-3-20210213","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.58.3.428","article-title":"Minicolumnar pathology in autism.","volume":"58","author":"Casanova","year":"2002","journal-title":"Neurology"},{"key":"R58-3-20210213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism.","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann Neurol"},{"key":"R59-3-20210213","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s007020050076","article-title":"Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate serotonin interactions for pharmacotherapy.","volume":"105","author":"Carlsson","year":"1998","journal-title":"J Neural Transm"},{"key":"R60-3-20210213","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.mp.4001499","article-title":"Autism as a disorder of neural information processing: directions for research and targets for therapy.","volume":"9","author":"Belmonte","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R61-3-20210213","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mrdd.20044","article-title":"Toward a developmental neurobiology of autism.","volume":"10","author":"Polleux","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R62-3-20210213","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1176\/ajp.2006.163.12.2189","article-title":"In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism.","volume":"163","author":"Page","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R63-3-20210213","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0140-6736(93)90754-5","article-title":"Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.","volume":"341","author":"During","year":"1993","journal-title":"Lancet"},{"key":"R64-3-20210213","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease.","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch Neurol"},{"key":"R65-3-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","article-title":"Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.","volume":"27","author":"Niederhofer","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R66-3-20210213","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0006-3223(00)00235-3","article-title":"Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study.","volume":"47","author":"Volz","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R67-3-20210213","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1192\/bjp.184.5.409","article-title":"Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla.","volume":"184","author":"Jensen","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R68-3-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pscychresns.2005.11.004","article-title":"Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.","volume":"146","author":"Jensen","year":"2006","journal-title":"Psychiatry Res"},{"key":"R69-3-20210213","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuroimage.2006.12.023","article-title":"Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.","volume":"35","author":"Smesny","year":"2007","journal-title":"Neuroimage"},{"key":"R70-3-20210213","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.yco.0000214337.29378.cd","article-title":"What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.","volume":"19","author":"Abbott","year":"2006","journal-title":"Curr Opin Psychiatry"},{"key":"R71-3-20210213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archpsyc.1991.01810310043008","article-title":"Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.","volume":"48","author":"Arnold","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R72-3-20210213","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.1995.03950220015005","article-title":"Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.","volume":"52","author":"Selemon","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"R73-3-20210213","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1073\/pnas.201243998","article-title":"Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia.","volume":"98","author":"Thompson","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R74-3-20210213","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0006-3223(98)00351-5","article-title":"An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects.","volume":"46","author":"Friedman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R75-3-20210213","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1098\/rstb.1996.0135","article-title":"Prefrontal function in schizophrenia: confounds and controversies. Philosophical transactions of the royal society of london B.","volume":"351","author":"Weinberger","year":"1996","journal-title":"Biol Sci"},{"key":"R76-3-20210213","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1176\/ajp.153.2.200","article-title":"Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production.","volume":"153","author":"Yurgelun-Todd","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R77-3-20210213","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","article-title":"Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.","volume":"30","author":"Steen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R78-3-20210213","first-page":"7","article-title":"Correlations between diffusion tensor imaging (dti) and magnetic resonance spectroscopy (1H MRS) in schizophrenic patients and normal controls.","volume":"19","author":"Tang","year":"2007","journal-title":"BMC Psychiatry"},{"key":"R79-3-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2007.03.028","article-title":"Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.","volume":"93","author":"Stanley","year":"2007","journal-title":"Schizophr Res"},{"key":"R80-3-20210213","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-3223(03)00185-9","article-title":"Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia.","volume":"54","author":"Fannon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R81-3-20210213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-3223(00)00997-5","article-title":"The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.","volume":"49","author":"Bertolino","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R82-3-20210213","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2001-18037","article-title":"Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.","volume":"34","author":"Braus","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R83-3-20210213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(02)00003-2","article-title":"Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia.","volume":"12","author":"Braus","year":"2002","journal-title":"Eur Neuropsychopharm"},{"key":"R84-3-20210213","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/156802606777057599","article-title":"Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.","volume":"6","author":"Lindsley","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"R85-3-20210213","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia.","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"R86-3-20210213","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neuroscience"},{"key":"R87-3-20210213","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","article-title":"Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.","volume":"18","author":"Adams","year":"1998","journal-title":"J Neurosci"},{"key":"R88-3-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90106-U","article-title":"MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis.","volume":"150","author":"Hasegawa","year":"1993","journal-title":"Neurosci Lett"},{"key":"R89-3-20210213","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0197-0186(94)90048-5","article-title":"Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat.","volume":"25","author":"Giovannini","year":"1994","journal-title":"Neurochem Int (Oxford)"},{"key":"R90-3-20210213","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.mp.4000529","article-title":"Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and a2-adrenergic agonists.","volume":"4","author":"Kim","year":"1999","journal-title":"Mol Psychiatry"},{"key":"R91-3-20210213","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.","volume":"160","author":"Theberge","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R92-3-20210213","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.","volume":"159","author":"Theberge","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R93-3-20210213","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.1983.01790090047007","article-title":"Genetic factors in anxiety disorders.","volume":"40","author":"Torgersen","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R94-3-20210213","first-page":"171","article-title":"The genetics of panic disorder and agoraphobia.","volume":"3","author":"Crowe","year":"1985","journal-title":"Psychiatr Dev"},{"key":"R95-3-20210213","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00006842-200107000-00017","article-title":"Slow recovery from voluntary hyperventilation in panic disorder.","volume":"63","author":"Wilhelm","year":"2001","journal-title":"Psychosom Med"},{"key":"R96-3-20210213","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM196712212772502","article-title":"Lactate metabolism in anxiety neurosis.","volume":"277","author":"Pitts","year":"1967","journal-title":"N Engl J Med"},{"key":"R97-3-20210213","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpsyc.1984.01790190038004","article-title":"Lactate provocation of panic attacks. I. Clinical and behavioral findings.","volume":"41","author":"Liebowitz","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"R98-3-20210213","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-3223(87)90152-1","article-title":"Biological markers in panic states: lactate-induced panic and mitral valve prolapse.","volume":"22","author":"Dager","year":"1987","journal-title":"Biol Psychiatry"},{"key":"R100-3-20210213","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archpsyc.1986.01800090090013","article-title":"Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.","volume":"43","author":"Woods","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"R101-3-20210213","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-1781(91)90020-P","article-title":"Elevated serum lactate associated with panic attacks induced by hyperventilation.","volume":"38","author":"Maddock","year":"1991","journal-title":"Psychiatry Res"},{"key":"R102-3-20210213","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0010-440X(03)00011-7","article-title":"Coping strategies of panic and control subjects undergoing lactate infusion during MRI confinement.","volume":"44","author":"Nazemi","year":"2003","journal-title":"Compr Psychiatry"},{"key":"R103-3-20210213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1176\/ajp.151.1.57","article-title":"Preliminary applications of magnetic resonance spectroscopy to investigate lactate-induced panic.","volume":"151","author":"Dager","year":"1994","journal-title":"Am J Psychiatry"},{"key":"R104-3-20210213","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0925-4927(97)00066-8","article-title":"Single-voxel 1H MRS investigation of brain metabolic changes during lactate-induced panic.","volume":"76","author":"Dager","year":"1997","journal-title":"Psychiatry Res"},{"key":"R105-3-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0925-4927(99)00053-0","article-title":"Modeling brain compartmental lactate response to metabolic challenge: a feasibility study.","volume":"98","author":"Friedman","year":"2000","journal-title":"Psychiatry Res"},{"key":"R106-3-20210213","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1073\/pnas.101129298","article-title":"Cerebral energetics and the glycogen shunt neurochemical basis of functional imaging.","volume":"98","author":"Shulman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R107-3-20210213","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.56.1.70","article-title":"Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic.","volume":"56","author":"Dager","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R108-3-20210213","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/da.1076","article-title":"Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment.","volume":"14","author":"Layton","year":"2001","journal-title":"Depress Anxiety"},{"key":"R109-3-20210213","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0925-4927(01)00082-8","article-title":"31P nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis.","volume":"106","author":"Yildiz","year":"2001","journal-title":"Psychiatry Res"},{"key":"R110-3-20210213","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/ajp.154.1.116","article-title":"Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.","volume":"154","author":"Moore","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R111-3-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s004060050052","article-title":"31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.","volume":"248","author":"Volz","year":"1998","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R112-3-20210213","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s004060050054","article-title":"Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.","volume":"248","author":"Kato","year":"1998","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R113-3-20210213","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","article-title":"Mitochondrial dysfunction in bipolar disorder.","volume":"2","author":"Kato","year":"2000","journal-title":"Bipolar Disord"},{"key":"R114-3-20210213","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0278-5846(94)90115-5","article-title":"Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy.","volume":"18","author":"Charles","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R115-3-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s004060050017","article-title":"Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.","volume":"248","author":"Hamakawa","year":"1998","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R116-3-20210213","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0006-3223(00)00942-2","article-title":"Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy.","volume":"48","author":"Steingard","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R117-3-20210213","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0006-3223(96)00256-9","article-title":"Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.","volume":"41","author":"Renshaw","year":"1997","journal-title":"Biol Psychiatry"},{"key":"R118-3-20210213","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1176\/ajp.156.10.1638","article-title":"Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.","volume":"156","author":"Sonawalla","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R119-3-20210213","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archpsyc.57.10.937","article-title":"The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.","volume":"57","author":"Ende","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R120-3-20210213","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pscychresns.2006.11.003","article-title":"Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy.","volume":"154","author":"Frye","year":"2007","journal-title":"Psychiatry Res"},{"key":"R121-3-20210213","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-8993(01)02566-5","article-title":"Induced mitochondrial failure in the feline brain: implications for understanding acute post-traumatic metabolic events.","volume":"908","author":"Clausen","year":"2001","journal-title":"Brain Res"},{"key":"R122-3-20210213","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0006-3223(03)00784-4","article-title":"Ethanolamine and phosphoethanolamine inhibit mitochondrial bioenergetic function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder.","volume":"55","author":"Modica-Napolitano","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R123-3-20210213","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.","volume":"53","author":"Manji","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R124-3-20210213","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","article-title":"Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.","volume":"56","author":"Friedman","year":"2004","journal-title":"Bio Psychiatry"},{"key":"R125-3-20210213","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical cg-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R126-3-20210213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of g-aminobutyric acid and glutamate in patients with major depression.","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R127-3-20210213","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT.","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R128-3-20210213","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors.","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R129-3-20210213","first-page":"1","article-title":"Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.","volume":"11","author":"Bhagwagar","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"R130-3-20210213","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0361-9230(01)00527-5","article-title":"Glial cell abnormalities in major psychiatric disorders: the evidence and implications.","volume":"55","author":"Cotter","year":"2001","journal-title":"Brain Res Bull"},{"key":"R131-3-20210213","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr Res"},{"key":"R132-3-20210213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R133-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1987.tb32889.x","article-title":"NMR: physical principles and current status as a biomedical technique.","volume":"508","author":"Becker","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"R134-3-20210213","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/mrm.21073","article-title":"9.4T human MRI: preliminary results.","volume":"56","author":"Vaughan","year":"2006","journal-title":"Magn Reson Med"},{"key":"R135-3-20210213","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.mri.2005.12.023","article-title":"Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T.","volume":"24","author":"Mangia","year":"2006","journal-title":"Magn Reson Imaging"},{"key":"R136-3-20210213","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mrm.1910340322","article-title":"Proton spectroscopic imaging of the human brain using phased array detectors.","volume":"34","author":"Wald","year":"1995","journal-title":"Magn Reson Med"},{"key":"R137-3-20210213","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1073\/pnas.82.6.1633","article-title":"IH-Observe\/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo.","volume":"82","author":"Rothman","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R138-3-20210213","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mri.2006.01.003","article-title":"In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective.","volume":"24","author":"Henry","year":"2006","journal-title":"Magn Reson Imaging"},{"key":"R139-3-20210213","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/nbm.1940010105","article-title":"Carbohydrate metabolism of the rat C6 glioma. An in vivo 13C and in vitro IH magnetic resonance spectroscopy study.","volume":"1","author":"Ross","year":"1988","journal-title":"NMR Biomed"},{"key":"R140-3-20210213","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1158\/0008-5472.CAN-06-2564","article-title":"Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis.","volume":"66","author":"Golman","year":"2006","journal-title":"Cancer Res"},{"key":"R141-3-20210213","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1073\/pnas.0601319103","article-title":"Real-time metabolic imaging.","volume":"103","author":"Golman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R142-3-20210213","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/appi.ajp.161.1.93","article-title":"Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator.","volume":"161","author":"Rohan","year":"2004","journal-title":"Am J Psychiatry"}],"container-title":["Topics in Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002142-200804000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T10:40:05Z","timestamp":1709203205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002142-200804000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rmr.0b013e318181e0be","relation":{},"ISSN":["0899-3459"],"issn-type":[{"value":"0899-3459","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}